TinyGemsBreaks Archive - Page 98 of 137

WednesdayDec 21, 2022 2:42 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower dose levels than other CBD formulations to achieve effective levels within the blood stream, as supported by this pharmaceutical-industry peer comparison,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “This is extremely important to patients…

WednesdayDec 21, 2022 1:57 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes filing of an environmental permit followed by construction permit application for phase 1 400,000 cubic meters (“CBM”) capacity. The latter will be a phased submission, with each phase designed in accordance with commercial storage requirements…

TuesdayDec 20, 2022 3:25 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

TuesdayDec 20, 2022 12:08 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st Annual J.P. Morgan Tech/Auto Forum. The forum is slated to take place at the Bellagio Hotel during CES 2023 in Las Vegas, Nevada, on Jan. 5, 2023. Cepton will participate in a fireside chat at the event at 2:20 p.m. PT on Thursday, Jan. 5. Interested parties should visit https://ibn.fm/2Sfvm to view a live audio webcast of the presentation. To view the full press release,…

TuesdayDec 20, 2022 11:37 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Wraps Up 2022 Mullen FIVE Strikingly Different Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, finished its innovative 2022 Mullen FIVE Strikingly Different Test Drive Tour with a last stop on Dec. 16, 2022, in Charlotte, North Carolina. The tour began Oct. 27, 2022, and featured stops in nine cities in the west, south, and southeastern parts of the country. According to the announcement, the tour was very successful; the company is already planning a follow-up spring tour with stops planned throughout the eastern, northwest and Midwest parts of the country. The fall tour featured the Mullen Five; the spring tour will feature the Mullen…

TuesdayDec 20, 2022 11:12 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary of its key milestone accomplishments in 2022. “2022 was a momentous year marked by steady progress across our pipeline of differentiated psychedelic-based therapeutics and partnerships targeting mental health. Most notable were the advancements of our two lead programs, CYB003 and CYB004, into clinical stage – within less than 18 months since discovery – which is a remarkable accomplishment and a true testament to the strength of our team,” said Cybin’s Chief Executive Officer Doug Drysdale. “Along with our clinical programs,…

FridayDec 16, 2022 3:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (‘CBD’) may potentially have therapeutic utility against diabetes,” a recent article reads. “Lexaria is optimistic that its DehydraTECH-CBD will yield notable results from this study, especially having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study. There is a strong connection between heart disease, hypertension and diabetes, with hypertension proving to…

FridayDec 16, 2022 11:11 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Contribute to Domestic Energy Security, Supply U308 to US Uranium Reserve

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements (“REE”), today announced that it has been awarded a contract to sell $18.5 million of natural uranium concentrates (“U3O8”) to the U.S. government for the establishment of a strategic “Uranium Reserve.” The U.S. National Nuclear Security Administration (“NNSA”), an office within the U.S. Department of Energy (“DOE”), is tasked with purchasing domestic U3O8 and conversion services for the Uranium Reserve, intended as a backup source of supply for domestic nuclear power plants in the event of a significant market disruption. “Energy Fuels is…

FridayDec 16, 2022 10:21 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and management information circular. Specifically, the election of directors was held, and shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders. Those directors included Eric Adams, Andrew Hull, Janet Grove, Bryan Baldasare, and Nicole Lemerond. To view…

ThursdayDec 15, 2022 3:51 pm

TinyGemsBreaks – MICT Inc. (NASDAQ: MICT) Regains Compliance with Nasdaq Listing Requirements

MICT (NASDAQ: MICT), which recently acquired the operating business and assets of Tingo (OTC: TMNA) (“Tingo Mobile Limited” or “Tingo Mobile”), announced that it has received a bid price compliance letter from the Nasdaq Stock Market LLC. The letter informs MICT that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq. MICT was previously notified that it was not in compliance with the rule due to its common stock failing to meet the closing bid price of $1.00 or more for 30 consecutive business days. To regain compliance,…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks